| Name | Title | Contact Details |
|---|
MDC Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Eisenhower Health, we offer a progressive environment with an emphasis on individual growth and advanced medical practices seldom seen in other hospitals. As a not-for-profit and comprehensive health care institution located in Southern California, we are the proud recipient of the 2009 Distinguished Hospital award for Excellence™ by HealthGrades® and the 2011 Gallup Great Workplace award. Located on 130 acres in Rancho Mirage, we offer our community a 476-bed acute care hospital with telemetry, critical care and medical/surgical floors. We also have a multitude of specialty centers including The Betty Ford Center, The Barbara Sinatra Children`s Center and The Annenberg Center for Health Sciences. Eisenhower is renowned for its Centers of Excellence in Orthopedics, ranked #1 in California for Joint Replacement three years in a row (2008, 2009 & 2010) in HealthGrades®, as well as its Centers of Excellence in Cardiovascular, Neuroscience and Oncology. Additionally, Eisenhower was the first hospital in Riverside and San Bernardino counties to be designated a Certified Primary Stroke Center by The Joint Commission. Eisenhower Health was also recently voted “The Top 20 Most Beautiful Hospitals” by Soliant Health, fostering a respectful, supportive and friendly work environment.
At Health IQ, we believe the best way to improve the health of the world is to celebrate the health conscious rather than harassing those who are not.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
PaxeraMed Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.